Stephane Depil
Nessuna posizione attualmente
Profilo
Stephane Depil served as the Chief Executive Officer of NETRIS Pharma SAS and as the Medical Director of the Cancer Immunotherapy Program at Centre Léon Bérard Lyon et Rhône-Alpes.
He also worked as the Chief Medical Officer and EVP-Research & Development at Cellectis SA from 2017 to 2019.
Depil holds a doctorate degree from Université de Lille III.
Precedenti posizioni note di Stephane Depil
| Società | Posizione | Fine |
|---|---|---|
| CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 01/02/2019 |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Chief Executive Officer | - |
| Centre Léon Bérard Lyon et Rhône-Alpes | Corporate Officer/Principal | - |
Formazione di Stephane Depil
| Université de Lille III | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Aziende private | 2 |
|---|---|
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Health Technology |
| Centre Léon Bérard Lyon et Rhône-Alpes |
- Borsa valori
- Insiders
- Stephane Depil
